U.S. FDA Will Have Risk-Based Import Screening System Up And Running By Year's End
This article was originally published in PharmAsia News
Executive Summary
Computer glitches have prevented implementation in all 10 U.S. FDA districts of an information technology system that flags high-risk imports for possible inspection, but the system has been effective in the four districts where it has been rolled out, Commissioner Margaret Hamburg reported to a U.S. Congressional panel April 13